LetterCancer

Response to comment on “NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis”

See allHide authors and affiliations

Science Translational Medicine  27 Jul 2016:
Vol. 8, Issue 349, pp. 349lr1
DOI: 10.1126/scitranslmed.aag1805

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Multiple factors may affect the outcome of diabetic patients with cancer treated with antioxidant antidiabetic agents.

View Full Text